POLY(ETHYLENE GLYCOL)-MODIFIED PHOSPHOLIPIDS PREVENT AGGREGATION DURING COVALENT CONJUGATION OF PROTEINS TO LIPOSOMES

被引:57
作者
HARASYM, TO [1 ]
TARDI, P [1 ]
LONGMAN, SA [1 ]
ANSELL, SM [1 ]
BALLY, MB [1 ]
CULLIS, PR [1 ]
CHOI, LSL [1 ]
机构
[1] BRITISH COLUMBIA CANC AGCY,DIV MED ONCOL,VANCOUVER,BC V5Z 4E6,CANADA
关键词
D O I
10.1021/bc00032a006
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Liposome aggregation is a major problem associated with the covalent attachment of proteins to liposomes. This report describes a procedure for coupling proteins to liposomes that results in little or no change in liposome size. This is achieved by incorporating appropriate levels of poly(ethylene glycol)-modified lipids into the liposomes. The studies employed thiolated avidin-D coupled to liposomes containing the thio-reactive lipid N-(4-(p-maleimidophenyl)butyryl)dipalmitoyl phosphatidylethanolamine (1 mol % of total lipid) and various amounts of MePEG-S-POPE (monomethoxypoly(ethylene glycol) linked to phosphatidylethanolamine via a succinate linkage). The influence of PEG chain length and density was also assessed. The presence of PEG on the surface of liposomes is shown to provide an effective method of inhibiting aggregation and the corresponding increase in liposome size during the covalent coupling of avidin-D. A balance between the size of the PEG used and the amount of PEG-lipid incorporated into the liposome had to be achieved in order to maintain efficient coupling. Optimal coupling efficiencies in combination with minimal aggregation effects were achieved using 2 mol % MePEG(2000)-S-POPE (PEG of 2000 MW) or 0.8 mol % MePEG(5000)-S-POPE (PEG of 5000 MW). At these levels, the presence of PEG did not affect the biotin binding activity of the covalently attached avidin. The ability of the resulting liposomes to specifically target to biotinylated cells is demonstrated.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 39 条
[1]  
AHMAD I, 1993, CANCER RES, V53, P1484
[2]  
Allen Theresa M., 1994, Journal of Liposome Research, V4, P1, DOI 10.3109/08982109409037027
[3]   GANGLIOSIDES REDUCE LEAKAGE OF AQUEOUS-SPACE MARKERS FROM LIPOSOMES IN THE PRESENCE OF HUMAN-PLASMA [J].
ALLEN, TM ;
RYAN, JL ;
PAPAHADJOPOULOS, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 818 (02) :205-210
[4]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[5]   IMMUNE CLEARANCE OF LIPOSOMES INHIBITED BY AN ANTI-FC RECEPTOR ANTIBODY INVIVO [J].
ARAGNOL, D ;
LESERMAN, LD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2699-2703
[6]  
BAKKERWOUDENBER.IA, 1992, BIOCHIM BIOPHYS ACTA, V1138, P318
[7]  
Bally M. B., 1988, LIPOSOMES DRUG CARRI, P841
[8]   TRANSFER OF LIPOSOMAL DRUG CARRIERS FROM THE BLOOD TO THE PERITONEAL-CAVITY OF NORMAL AND ASCITIC TUMOR-BEARING MICE [J].
BALLY, MB ;
MASIN, D ;
NAYAR, R ;
CULLIS, PR ;
MAYER, LD .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (02) :137-146
[9]   LIPOSOMES WITH ENTRAPPED DOXORUBICIN EXHIBIT EXTENDED BLOOD RESIDENCE TIMES [J].
BALLY, MB ;
NAYAR, R ;
MASIN, D ;
HOPE, MJ ;
CULLIS, PR ;
MAYER, LD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1023 (01) :133-139
[10]  
BALLY MB, 1993, LIPOSOME TECHNOLOGY, P27